Idir Ouzaïd
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Kidney Stones and Urolithiasis Treatments
- Prostate Cancer Treatment and Research
- Urology top 2%
Papers in
-
- Renal cell carcinoma treatment 33
- Prostate Cancer Diagnosis and Treatment 20
- Prostate Cancer Treatment and Research 12
- Surgery 50
- Bladder and Urothelial Cancer Treatments 32
- Urinary and Genital Oncology Studies 19
- Co-authors
- Évanguelos Xylinas (33 shared papers)Jean‐François Hermieu (19 shared papers)Umberto Capitanio (12 shared papers)V. Ravery (16 shared papers)Morgan Rouprêt (14 shared papers)Alexandre de la Taille (15 shared papers)Laurent Salomon (14 shared papers)Maximilian C. Kriegmair (8 shared papers)
- Journals
- Urology (6 papers)World Journal of Urology (5 papers)British Journal of Urology (5 papers)European Urology Oncology (4 papers)European Urology (4 papers)
- Partner nations
- FranceItalyUnited States
In The Last Decade
Idir Ouzaïd
89 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 84
- Pulmonary and Respiratory Medicine 947
- Urology 176
- Surgery 720
- Rheumatology 151
- Cancer Research 134
Countries citing papers authored by Idir Ouzaïd
This map shows the geographic impact of Idir Ouzaïd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Idir Ouzaïd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Idir Ouzaïd more than expected).
Fields of papers citing papers by Idir Ouzaïd
This network shows the impact of papers produced by Idir Ouzaïd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Idir Ouzaïd. The network helps show where Idir Ouzaïd may publish in the future.
Co-authors
The 25 scholars most cited alongside Idir Ouzaïd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 137 | |
| 2 | 2012 | 114 | |
| 3 | 2010 | 96 | |
| 4 | 2018 | 81 | |
| 5 | 2018 | 79 | |
| 6 | 2013 | 65 | |
| 7 | 2016 | 61 | |
| 8 | 2011 | 48 | |
| 9 | 2018 | 47 | |
| 10 | 2022 | 41 | |
| 11 | 2018 | 40 | |
| 12 | 2018 | 35 | |
| 13 | 2013 | 35 | |
| 14 | 2012 | 33 | |
| 15 | 2010 | 31 | |
| 16 | 2020 | 29 | |
| 17 | 2017 | 24 | |
| 18 | 2021 | 24 | |
| 19 | 2015 | 22 | |
| 20 | 2021 | 20 |
About Idir Ouzaïd
Idir Ouzaïd is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Urology, Molecular Biology and Rheumatology, having authored 100 papers that have together received 1.5k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (33 papers), Bladder and Urothelial Cancer Treatments (32 papers), Prostate Cancer Diagnosis and Treatment (20 papers), Urological Disorders and Treatments (20 papers), Urinary and Genital Oncology Studies (19 papers), Renal and related cancers (18 papers), Urinary Bladder and Prostate Research (12 papers) and Prostate Cancer Treatment and Research (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (947 citations), Urology (176 citations), Surgery (720 citations), Rheumatology (151 citations) and Cancer Research (134 citations). Idir Ouzaïd has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Évanguelos Xylinas, Jean‐François Hermieu, Umberto Capitanio, V. Ravery, Morgan Rouprêt, Alexandre de la Taille, Laurent Salomon, Maximilian C. Kriegmair, Riccardo Bertolo and Maciej Salagierski. Their work appears in journals such as Urology, World Journal of Urology, British Journal of Urology, European Urology Oncology and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.